Literature DB >> 3396952

Recurrence and re-recurrence of gall stones after medical dissolution: a longterm follow up.

L D O'Donnell1, K W Heaton.   

Abstract

One hundred patients with radiolucent gall stones less than or equal to 1.5 cm in functioning gall bladders have received oral bile acid dissolution therapy since 1975. Complete data are available on 93 who have received at least six months' treatment. The complete dissolution rate in appropriately selected patients who complied with and tolerated an adequate course of treatment was 55%. By life table analysis the recurrence rates were 13% at one year, 21% at two years, 31% at three years, and 43% at four years. Thereafter the recurrence rate levelled out, being 49% at 11 years. Redissolution was achieved in all seven patients who had a second course of therapy, but was usually followed by re-recurrence. Patients whose gall stones recurred did not differ significantly from those who remained stone free with respect to age, sex, body weight, or time required for dissolution.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396952      PMCID: PMC1433655          DOI: 10.1136/gut.29.5.655

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side-effects in patients with gallstones.

Authors:  H Y Mok; G D Bell; R H Dowling
Journal:  Lancet       Date:  1974-08-03       Impact factor: 79.321

2.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-08       Impact factor: 3.199

3.  Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy.

Authors:  J H Iser; H Dowling; H Y Mok; G D Bell
Journal:  N Engl J Med       Date:  1975-08-21       Impact factor: 91.245

4.  Is recurrence inevitable after gallstone dissolution by bile-acid treatment?

Authors:  D C Ruppin; R H Dowling
Journal:  Lancet       Date:  1982-01-23       Impact factor: 79.321

5.  Influence of gallstones and ursodeoxycholic acid therapy on gallbladder emptying.

Authors:  I C Forgacs; M N Maisey; G M Murphy; R H Dowling
Journal:  Gastroenterology       Date:  1984-08       Impact factor: 22.682

6.  Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrence.

Authors:  P N Maton; J H Iser; A Reuben; H M Saxton; G M Murphy; R H Dowling
Journal:  Medicine (Baltimore)       Date:  1982-03       Impact factor: 1.889

7.  Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible?

Authors:  J H Iser; G M Murphy; R H Dowling
Journal:  Gut       Date:  1977-01       Impact factor: 23.059

8.  Evidence for a potent nucleating factor in the gallbladder bile of patients with cholesterol gallstones.

Authors:  M J Burnstein; R G Ilson; C N Petrunka; R D Taylor; S M Strasberg
Journal:  Gastroenterology       Date:  1983-10       Impact factor: 22.682

9.  Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease.

Authors:  K R Holan; R T Holzbach; R E Hermann; A M Cooperman; W J Claffey
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

Review 10.  Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety.

Authors:  L J Schoenfield; J M Lachin
Journal:  Ann Intern Med       Date:  1981-09       Impact factor: 25.391

View more
  23 in total

1.  Multifactorial analysis of recurrence of cholecy_stolithiasis in Shanghai area.

Authors:  Pei Chen; Bing-Sheng Wang; Lian-Qi He
Journal:  World J Gastroenterol       Date:  1999-02       Impact factor: 5.742

Review 2.  Extracorporeal biliary lithotripsy and direct chemolitholysis-an integrated concept.

Authors:  W Domschke
Journal:  Gastroenterol Jpn       Date:  1989-10

3.  Lithotripsy versus cholecystectomy for management of gallstones. A decision analysis by Markov process.

Authors:  A Sonnenberg; G A Derfus; K H Soergel
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

4.  Dissolution of gallbladder stones with methyl tert-butyl ether and stone recurrence: a European survey.

Authors:  A Hellstern; U Leuschner; A Benjaminov; H Ackermann; T Heine; D Festi; M Orsini; E Roda; T C Northfield; R Jazrawi; W Kurtz; H J Schmeck-Lindenau; J Stumpf; B E Eidsvoll; E Aadland; G Lux; E Boehnke; D Wurbs; M Delhaye; M Cremer; I Sinn; E Höring; U v Gaisberg; M Neubrand; F Paul
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

5.  Gallstone recurrence after direct contact dissolution with methyl tert-butyl ether.

Authors:  J Pauletzki; J Holl; M Sackmann; M Neubrand; U Klueppelberg; T Sauerbruch; G Paumgartner
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

6.  Effect of aspirin on gallbladder motility in patients with gallstone disease. A randomized, double-blind, placebo-controlled trial of two dosage schedules.

Authors:  A Das; S S Baijal; V A Saraswat
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

7.  Gall stone pulverisation strategy in patients treated with extracorporeal lithotripsy and follow up results of maintenance treatment with ursodeoxycholic acid.

Authors:  M Boscaini; M Piccinni-Leopardi; F Andreotti; A Montori
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

8.  Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial.

Authors:  K A Hood; D Gleeson; D C Ruppin; R H Dowling
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

9.  Percutaneous cholecystolithotomy: is gall stone recurrence inevitable?

Authors:  J J Donald; S Cheslyn-Curtis; A R Gillams; R C Russell; W R Lees
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

10.  Role of extracorporeal shock wave lithotripsy in hepato-biliary-pancreatic surgery.

Authors:  R L van der Hul; P W Plaisier; O T Terpstra; H A Bruining
Journal:  World J Surg       Date:  1993 Sep-Oct       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.